Literature DB >> 12230511

Expression of transglutaminase 5 in normal and pathologic human epidermis.

Eleonora Candi1, Sergio Oddi, Andrea Paradisi, Alessandro Terrinoni, Marco Ranalli, Patrizia Teofoli, Gennaro Citro, Silvia Scarpato, Pietro Puddu, Gerry Melino.   

Abstract

To explore the expression and gain more information on the function of transglutaminase 5 enzyme in normal and defective human epidermis, we generated a rat antihuman transglutaminase 5 antiserum elicited against a purified active recombinant protein expressed in the baculovirus system. By use of Western blotting and immunofluorescence methods, the immunospecificity of the antibodies for transglutaminase 5 was tested; no crossreactivity with other transglutaminases (types 1, 2, and 3) was observed, thus allowing histochemistry studies. By indirect immunofluorescence analysis the antibodies decorated the upper layers of normal human epidermis, with consistent staining in the spinous and granular layers. We evaluated transglutaminase 5 expression in comparison with proliferating (keratin 14) and differentiating (transglutaminase 3) markers in different diseases, such as psoriasis, ichthyosis vulgaris, lamellar ichthyosis, and Darier's disease. We observed that transglutaminase 5 contributes, as a secondary effect, to the hyperkeratotic phenotype in ichthyosis (both vulgaris and lamellar) and in psoriasis. In Darier's disease, transglutaminase 5 expression, as well as transglutaminase 3, is completely missregulated, being overexpressed or totally absent in different areas of the same lesion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230511     DOI: 10.1046/j.1523-1747.2002.01853.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  23 in total

1.  Luteolin induces caspase-14-mediated terminal differentiation in human epidermal keratinocytes.

Authors:  V Cijo George; D R Naveen Kumar; P K Suresh; R Ashok Kumar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-10-01       Impact factor: 2.416

2.  Transglutaminases, involucrin, and loricrin as markers of epidermal differentiation in skin substitutes derived from human sweat gland cells.

Authors:  Sasha Tharakan; Luca Pontiggia; Thomas Biedermann; Sophie Böttcher-Haberzeth; Clemens Schiestl; Ernst Reichmann; Martin Meuli
Journal:  Pediatr Surg Int       Date:  2010-01       Impact factor: 1.827

Review 3.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

Review 4.  Transglutaminases: part I-origins, sources, and biotechnological characteristics.

Authors:  Lovaine Duarte; Carla Roberta Matte; Cristiano Valim Bizarro; Marco Antônio Záchia Ayub
Journal:  World J Microbiol Biotechnol       Date:  2020-01-02       Impact factor: 3.312

5.  The antipsoriatic agent monomethylfumarate has antiproliferative, prodifferentiative, and anti-inflammatory effects on keratinocytes.

Authors:  Inas Helwa; Ravi Patel; Peter Karempelis; Ismail Kaddour-Djebbar; Vivek Choudhary; Wendy B Bollag
Journal:  J Pharmacol Exp Ther       Date:  2014-10-20       Impact factor: 4.030

6.  Dietary glucosylceramide enhances cornified envelope formation via transglutaminase expression and involucrin production.

Authors:  Tatsuya Hasegawa; Haruo Shimada; Taro Uchiyama; Osamu Ueda; Masaya Nakashima; Yasuhiro Matsuoka
Journal:  Lipids       Date:  2011-03-17       Impact factor: 1.880

7.  Tissue-specific responses to loss of transglutaminase 2.

Authors:  Stephanie Deasey; Shobana Shanmugasundaram; Maria Nurminskaya
Journal:  Amino Acids       Date:  2011-12-23       Impact factor: 3.520

8.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

9.  Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures.

Authors:  Saskia Lippens; Mark Kockx; Geertrui Denecker; Michiel Knaapen; An Verheyen; Ruben Christiaen; Erwin Tschachler; Peter Vandenabeele; Wim Declercq
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 10.  TIG3: a regulator of type I transglutaminase activity in epidermis.

Authors:  Richard L Eckert; Michael T Sturniolo; Ralph Jans; Catherine A Kraft; Haibing Jiang; Ellen A Rorke
Journal:  Amino Acids       Date:  2008-07-09       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.